In a pregnant woman with a TSH of 4.5 mIU/L and no prior thyroid medication, what starting dose of levothyroxine (Eltroxin) should be initiated?

Levothyroxine Dosing for TSH 4.5 mIU/L in Pregnancy

In a pregnant woman with TSH 4.5 mIU/L and no prior thyroid medication, start levothyroxine at 75–100 µg daily immediately, targeting TSH <2.5 mIU/L in the first trimester, and recheck thyroid function every 4 weeks until stable. 1, 2, 3

Immediate Treatment Rationale

• Pregnancy-specific TSH thresholds are lower than non-pregnant adults: any TSH elevation above 2.5 mIU/L in the first trimester warrants treatment, making a TSH of 4.5 mIU/L clearly abnormal and requiring immediate intervention 1, 3
• Untreated or inadequately treated maternal hypothyroidism increases risks of preeclampsia, low birth weight, placental abruption, fetal death, and permanent neurodevelopmental deficits in the child 1, 4, 5
• First-trimester hypothyroidism is specifically linked to cognitive impairment in offspring, because the fetus relies entirely on maternal thyroid hormone for brain development during this critical period 1, 5
• Women who receive early treatment in pregnancy do not experience increased perinatal morbidity, emphasizing the importance of rapid normalization 1

Starting Dose Selection

For new-onset hypothyroidism in pregnancy with TSH 4.5 mIU/L, the evidence supports two dosing strategies:

Weight-Based Dosing (Preferred)

• Start at 1.0–1.2 µg/kg/day for TSH 4.5 mIU/L 2, 3
• For a 70 kg woman, this translates to approximately 70–85 µg daily (round to 75 µg) 3
• This approach achieves euthyroidism in 89% of patients without requiring dose adjustments 3

Fixed-Dose Strategy

• Start at 75 µg daily for TSH between 4.2–10 mIU/L 6, 3
• This dose maintains TSH in the therapeutic goal range for 82% of patients 6
• Only 17.6% require additional dose adjustments during pregnancy 6

Higher Initial Doses for More Elevated TSH

• If TSH were >10 mIU/L (overt hypothyroidism), the starting dose would be 1.6 µg/kg/day or approximately 100–112 µg daily 2, 3
• For TSH 4.5 mIU/L, starting at 100 µg is reasonable if the patient weighs >85 kg or if you want to ensure rapid normalization 3

Monitoring Protocol

• Recheck TSH and free T4 every 4 weeks after initiation and after any dose adjustment 1, 2, 6
• Target TSH <2.5 mIU/L in the first trimester, then <3.0 mIU/L in the second and third trimesters 1, 6, 3
• Maintain free T4 in the high-normal range using the lowest possible medication dose 1
• Continue monitoring every 4 weeks through midgestation, then at 30 weeks 4

Dose Adjustment Strategy

• If TSH remains elevated at 4-week follow-up, increase levothyroxine by 12.5–25 µg 1, 2
• Serum TSH changes quickly and decreases significantly within 4 weeks of starting therapy 6
• Free T4 responds more slowly, with maximal change occurring around 12 weeks gestation 6
• Approximately 10–20% of patients require one or more dose adjustments during the second and third trimesters 6

Critical Safety Considerations

• Do not wait for TSH results before starting treatment—fetal harm can occur before maternal symptoms appear 1
• Measure anti-TPO antibodies to identify autoimmune thyroiditis, which predicts higher progression risk and may influence long-term management 7, 1
• If the patient has isolated hypothyroxinemia (low free T4 with normal TSH), measure TPO antibodies to exclude autoimmune disease, as positive antibodies reclassify the condition as subclinical hypothyroidism requiring treatment 1

Common Pitfalls to Avoid

• Never use the non-pregnant TSH reference range (0.5–4.5 mIU/L) in pregnancy—pregnancy-specific targets are lower 1, 3
• Avoid starting at doses <1.0 µg/kg/day for TSH 4.5 mIU/L, as this delays normalization and increases the need for multiple adjustments 3
• Do not mistake isolated hypothyroxinemia (normal TSH, low free T4) for subclinical hypothyroidism (elevated TSH, normal free T4)—the latter requires levothyroxine treatment during pregnancy 1
• Avoid TSH targets >2.5 mIU/L in the first trimester, as even subclinical hypothyroidism is associated with adverse pregnancy outcomes 1

Post-Delivery Management

• Reduce levothyroxine dose to pre-pregnancy levels immediately after delivery 2
• Monitor serum TSH 4–8 weeks postpartum to confirm appropriate dosing 2